As the cost of bringing new drugs to the market continues to rise, a afail fast, fail cheap' motto is being pursued through rational drug design to incorporate desirable properties into not only in drugs, but also through the generation of larger numbers of drug-like molecules using combinatorial chemistry methodologies, and the identification and elimination of problematic drugs early.
The new drug discovery brochure from Acros Organics lists more than 1000 recent additions to select product families of interest to today's drug discovery chemist, along relevant technical information.
New introductions which are now featured in the drug discovery brochure include:
€ A large selection of small organic molecules.
€ A wide range of chiral building blocks.
€ A diverse selection of scaffolds.
€ Advanced intermediates to enhance the productivity. u Innovativeness of structure activity relationship (SAR) studies.
A broad range of resins for solid phase synthesis and solution phase synthesis and a large selection of boronic acids complete this exiting offer for the medicinal chemist.
The brochure also highlights Acros Organics' collaboration with Chirotech, a world leader in chirality and the application of technology of supplying high purity, complex chemical intermediates and pharmaceutical agents.
ENQUIRY No 64
Acros Organics is based Geel, Belgium. www.acros.com
